secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2021-12-15T23:59:59+00:00
Accession:  0001193125-21-357968
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin appoints Mark J. Alles to Board of Directors, effective Jan 1, 2022
----------------------------------------------------------------------------

- Board size increased from ten to eleven members; Alles appointed to Board and Audit Committee.
- Appointment effective January 1, 2022; conditions satisfied December 10, 2021.
- Alles to receive standard independent director compensation and pro rata RSU grant ($400,000 annual value).
- No arrangement or understanding with any person for the appointment; no related party transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312521357968/0001193125-21-357968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312521357968/d265991d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-357968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer